These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18046705)

  • 1. Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide.
    Liu G; Li Y; Pagel MD
    Magn Reson Med; 2007 Dec; 58(6):1249-56. PubMed ID: 18046705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring in vivo tumor pHe with CEST-FISP MRI.
    Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD
    Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved pH measurements with a single PARACEST MRI contrast agent.
    Sheth VR; Liu G; Li Y; Pagel MD
    Contrast Media Mol Imaging; 2012; 7(1):26-34. PubMed ID: 22344877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biomarker-responsive T
    Daryaei I; Randtke EA; Pagel MD
    Magn Reson Med; 2017 Apr; 77(4):1665-1670. PubMed ID: 27090199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
    Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
    Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.
    Liu G; Li Y; Sheth VR; Pagel MD
    Mol Imaging; 2012 Feb; 11(1):47-57. PubMed ID: 22418027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Frequency-Selective pH-Responsive paraCEST Agent.
    Ratnakar SJ; Chirayil S; Funk AM; Zhang S; Queiró JF; Geraldes CFGC; Kovacs Z; Sherry AD
    Angew Chem Int Ed Engl; 2020 Nov; 59(48):21671-21676. PubMed ID: 32726500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-responsive PARACEST MRI contrast agents: a new biomedical imaging approach for studies of the proteasome.
    Yoo B; Raam MS; Rosenblum RM; Pagel MD
    Contrast Media Mol Imaging; 2007 Jul; 2(4):189-98. PubMed ID: 17712869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T.
    Li AX; Suchy M; Li C; Gati JS; Meakin S; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2011 Jul; 66(1):67-72. PubMed ID: 21254213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized MRI contrast for on-resonance proton exchange processes of PARACEST agents in biological systems.
    Li AX; Suchy M; Jones CK; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2009 Nov; 62(5):1282-91. PubMed ID: 19780147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lanthanide complexes of triethylenetetramine tetra-, penta-, and hexaacetamide ligands as paramagnetic chemical exchange-dependent saturation transfer contrast agents for magnetic resonance imaging: nona- versus decadentate coordination.
    Burdinski D; Pikkemaat JA; Lub J; de Peinder P; Nieto Garrido L; Weyhermüller T
    Inorg Chem; 2009 Jul; 48(14):6692-712. PubMed ID: 19507818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
    Winter PM; Cai K; Chen J; Adair CR; Kiefer GE; Athey PS; Gaffney PJ; Buff CE; Robertson JD; Caruthers SD; Wickline SA; Lanza GM
    Magn Reson Med; 2006 Dec; 56(6):1384-8. PubMed ID: 17089356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoquinoline-based lanthanide complexes: bright NIR optical probes and efficient MRI agents.
    Caillé F; Bonnet CS; Buron F; Villette S; Helm L; Petoud S; Suzenet F; Tóth E
    Inorg Chem; 2012 Feb; 51(4):2522-32. PubMed ID: 22233349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology.
    Winter PM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):389-98. PubMed ID: 22422650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of a PARACEST agent for MRI through selective outersphere interactions with phosphate diesters.
    Huang CH; Hammell J; Ratnakar SJ; Sherry AD; Morrow JR
    Inorg Chem; 2010 Jul; 49(13):5963-70. PubMed ID: 20509631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity.
    Li Y; Sheth VR; Liu G; Pagel MD
    Contrast Media Mol Imaging; 2011; 6(4):219-28. PubMed ID: 21861282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWIFT-CEST: a new MRI method to overcome T₂ shortening caused by PARACEST contrast agents.
    Soesbe TC; Togao O; Takahashi M; Sherry AD
    Magn Reson Med; 2012 Sep; 68(3):816-21. PubMed ID: 22213371
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.